Global Prescription Arthritis Medications Market Growth 2025-2031

December 2025 | 104 pages | ID: G806178E18AEN
LP Information

Abstracts

The global Prescription Arthritis Medications market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Prescription Arthritis Medications Industry Forecast” looks at past sales and reviews total world Prescription Arthritis Medications sales in 2024, providing a comprehensive analysis by region and market sector of projected Prescription Arthritis Medications sales for 2025 through 2031. With Prescription Arthritis Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prescription Arthritis Medications industry.

This Insight Report provides a comprehensive analysis of the global Prescription Arthritis Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prescription Arthritis Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prescription Arthritis Medications market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prescription Arthritis Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prescription Arthritis Medications.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Arthritis Medications market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral
• Topical

Segmentation by Application:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Abbott
• Amgen
• Boehringer Ingelheim
• Horizon Pharma
• Novartis
• Pfizer
• Regeneron

Key Questions Addressed in this Report

What is the 10-year outlook for the global Prescription Arthritis Medications market?

What factors are driving Prescription Arthritis Medications market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Prescription Arthritis Medications market opportunities vary by end market size?

How does Prescription Arthritis Medications break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Prescription Arthritis Medications Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Prescription Arthritis Medications by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Prescription Arthritis Medications by Country/Region, 2020, 2024 & 2031
2.2 Prescription Arthritis Medications Segment by Type
  2.2.1 Oral
  2.2.2 Topical
2.3 Prescription Arthritis Medications Sales by Type
  2.3.1 Global Prescription Arthritis Medications Sales Market Share by Type (2020-2025)
  2.3.2 Global Prescription Arthritis Medications Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Prescription Arthritis Medications Sale Price by Type (2020-2025)
2.4 Prescription Arthritis Medications Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Online Pharmacies
  2.4.3 Retail Pharmacies
2.5 Prescription Arthritis Medications Sales by Application
  2.5.1 Global Prescription Arthritis Medications Sale Market Share by Application (2020-2025)
  2.5.2 Global Prescription Arthritis Medications Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Prescription Arthritis Medications Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Prescription Arthritis Medications Breakdown Data by Company
  3.1.1 Global Prescription Arthritis Medications Annual Sales by Company (2020-2025)
  3.1.2 Global Prescription Arthritis Medications Sales Market Share by Company (2020-2025)
3.2 Global Prescription Arthritis Medications Annual Revenue by Company (2020-2025)
  3.2.1 Global Prescription Arthritis Medications Revenue by Company (2020-2025)
  3.2.2 Global Prescription Arthritis Medications Revenue Market Share by Company (2020-2025)
3.3 Global Prescription Arthritis Medications Sale Price by Company
3.4 Key Manufacturers Prescription Arthritis Medications Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Prescription Arthritis Medications Product Location Distribution
  3.4.2 Players Prescription Arthritis Medications Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PRESCRIPTION ARTHRITIS MEDICATIONS BY GEOGRAPHIC REGION

4.1 World Historic Prescription Arthritis Medications Market Size by Geographic Region (2020-2025)
  4.1.1 Global Prescription Arthritis Medications Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Prescription Arthritis Medications Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Prescription Arthritis Medications Market Size by Country/Region (2020-2025)
  4.2.1 Global Prescription Arthritis Medications Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Prescription Arthritis Medications Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prescription Arthritis Medications Sales Growth
4.4 APAC Prescription Arthritis Medications Sales Growth
4.5 Europe Prescription Arthritis Medications Sales Growth
4.6 Middle East & Africa Prescription Arthritis Medications Sales Growth

5 AMERICAS

5.1 Americas Prescription Arthritis Medications Sales by Country
  5.1.1 Americas Prescription Arthritis Medications Sales by Country (2020-2025)
  5.1.2 Americas Prescription Arthritis Medications Revenue by Country (2020-2025)
5.2 Americas Prescription Arthritis Medications Sales by Type (2020-2025)
5.3 Americas Prescription Arthritis Medications Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Prescription Arthritis Medications Sales by Region
  6.1.1 APAC Prescription Arthritis Medications Sales by Region (2020-2025)
  6.1.2 APAC Prescription Arthritis Medications Revenue by Region (2020-2025)
6.2 APAC Prescription Arthritis Medications Sales by Type (2020-2025)
6.3 APAC Prescription Arthritis Medications Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Prescription Arthritis Medications by Country
  7.1.1 Europe Prescription Arthritis Medications Sales by Country (2020-2025)
  7.1.2 Europe Prescription Arthritis Medications Revenue by Country (2020-2025)
7.2 Europe Prescription Arthritis Medications Sales by Type (2020-2025)
7.3 Europe Prescription Arthritis Medications Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Prescription Arthritis Medications by Country
  8.1.1 Middle East & Africa Prescription Arthritis Medications Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Prescription Arthritis Medications Revenue by Country (2020-2025)
8.2 Middle East & Africa Prescription Arthritis Medications Sales by Type (2020-2025)
8.3 Middle East & Africa Prescription Arthritis Medications Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Arthritis Medications
10.3 Manufacturing Process Analysis of Prescription Arthritis Medications
10.4 Industry Chain Structure of Prescription Arthritis Medications

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Prescription Arthritis Medications Distributors
11.3 Prescription Arthritis Medications Customer

12 WORLD FORECAST REVIEW FOR PRESCRIPTION ARTHRITIS MEDICATIONS BY GEOGRAPHIC REGION

12.1 Global Prescription Arthritis Medications Market Size Forecast by Region
  12.1.1 Global Prescription Arthritis Medications Forecast by Region (2026-2031)
  12.1.2 Global Prescription Arthritis Medications Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Prescription Arthritis Medications Forecast by Type (2026-2031)
12.7 Global Prescription Arthritis Medications Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Abbott
  13.1.1 Abbott Company Information
  13.1.2 Abbott Prescription Arthritis Medications Product Portfolios and Specifications
  13.1.3 Abbott Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Abbott Main Business Overview
  13.1.5 Abbott Latest Developments
13.2 Amgen
  13.2.1 Amgen Company Information
  13.2.2 Amgen Prescription Arthritis Medications Product Portfolios and Specifications
  13.2.3 Amgen Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Amgen Main Business Overview
  13.2.5 Amgen Latest Developments
13.3 Boehringer Ingelheim
  13.3.1 Boehringer Ingelheim Company Information
  13.3.2 Boehringer Ingelheim Prescription Arthritis Medications Product Portfolios and Specifications
  13.3.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Boehringer Ingelheim Main Business Overview
  13.3.5 Boehringer Ingelheim Latest Developments
13.4 Horizon Pharma
  13.4.1 Horizon Pharma Company Information
  13.4.2 Horizon Pharma Prescription Arthritis Medications Product Portfolios and Specifications
  13.4.3 Horizon Pharma Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Horizon Pharma Main Business Overview
  13.4.5 Horizon Pharma Latest Developments
13.5 Novartis
  13.5.1 Novartis Company Information
  13.5.2 Novartis Prescription Arthritis Medications Product Portfolios and Specifications
  13.5.3 Novartis Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Novartis Main Business Overview
  13.5.5 Novartis Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Prescription Arthritis Medications Product Portfolios and Specifications
  13.6.3 Pfizer Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Regeneron
  13.7.1 Regeneron Company Information
  13.7.2 Regeneron Prescription Arthritis Medications Product Portfolios and Specifications
  13.7.3 Regeneron Prescription Arthritis Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Regeneron Main Business Overview
  13.7.5 Regeneron Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Prescription Arthritis Medications Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Prescription Arthritis Medications Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Topical
Table 5. Global Prescription Arthritis Medications Sales by Type (2020-2025) & (K Units)
Table 6. Global Prescription Arthritis Medications Sales Market Share by Type (2020-2025)
Table 7. Global Prescription Arthritis Medications Revenue by Type (2020-2025) & ($ million)
Table 8. Global Prescription Arthritis Medications Revenue Market Share by Type (2020-2025)
Table 9. Global Prescription Arthritis Medications Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Prescription Arthritis Medications Sale by Application (2020-2025) & (K Units)
Table 11. Global Prescription Arthritis Medications Sale Market Share by Application (2020-2025)
Table 12. Global Prescription Arthritis Medications Revenue by Application (2020-2025) & ($ million)
Table 13. Global Prescription Arthritis Medications Revenue Market Share by Application (2020-2025)
Table 14. Global Prescription Arthritis Medications Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Prescription Arthritis Medications Sales by Company (2020-2025) & (K Units)
Table 16. Global Prescription Arthritis Medications Sales Market Share by Company (2020-2025)
Table 17. Global Prescription Arthritis Medications Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Prescription Arthritis Medications Revenue Market Share by Company (2020-2025)
Table 19. Global Prescription Arthritis Medications Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Prescription Arthritis Medications Producing Area Distribution and Sales Area
Table 21. Players Prescription Arthritis Medications Products Offered
Table 22. Prescription Arthritis Medications Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Prescription Arthritis Medications Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Prescription Arthritis Medications Sales Market Share Geographic Region (2020-2025)
Table 27. Global Prescription Arthritis Medications Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Prescription Arthritis Medications Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Prescription Arthritis Medications Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Prescription Arthritis Medications Sales Market Share by Country/Region (2020-2025)
Table 31. Global Prescription Arthritis Medications Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Prescription Arthritis Medications Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Prescription Arthritis Medications Sales by Country (2020-2025) & (K Units)
Table 34. Americas Prescription Arthritis Medications Sales Market Share by Country (2020-2025)
Table 35. Americas Prescription Arthritis Medications Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Prescription Arthritis Medications Sales by Type (2020-2025) & (K Units)
Table 37. Americas Prescription Arthritis Medications Sales by Application (2020-2025) & (K Units)
Table 38. APAC Prescription Arthritis Medications Sales by Region (2020-2025) & (K Units)
Table 39. APAC Prescription Arthritis Medications Sales Market Share by Region (2020-2025)
Table 40. APAC Prescription Arthritis Medications Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Prescription Arthritis Medications Sales by Type (2020-2025) & (K Units)
Table 42. APAC Prescription Arthritis Medications Sales by Application (2020-2025) & (K Units)
Table 43. Europe Prescription Arthritis Medications Sales by Country (2020-2025) & (K Units)
Table 44. Europe Prescription Arthritis Medications Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Prescription Arthritis Medications Sales by Type (2020-2025) & (K Units)
Table 46. Europe Prescription Arthritis Medications Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Prescription Arthritis Medications Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Prescription Arthritis Medications Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Prescription Arthritis Medications Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Prescription Arthritis Medications Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Prescription Arthritis Medications
Table 52. Key Market Challenges & Risks of Prescription Arthritis Medications
Table 53. Key Industry Trends of Prescription Arthritis Medications
Table 54. Prescription Arthritis Medications Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Prescription Arthritis Medications Distributors List
Table 57. Prescription Arthritis Medications Customer List
Table 58. Global Prescription Arthritis Medications Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Prescription Arthritis Medications Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Prescription Arthritis Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Prescription Arthritis Medications Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Prescription Arthritis Medications Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Prescription Arthritis Medications Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Prescription Arthritis Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Prescription Arthritis Medications Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Prescription Arthritis Medications Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Prescription Arthritis Medications Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Prescription Arthritis Medications Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Prescription Arthritis Medications Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Prescription Arthritis Medications Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Prescription Arthritis Medications Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Abbott Basic Information, Prescription Arthritis Medications Manufacturing Base, Sales Area and Its Competitors
Table 73. Abbott Prescription Arthritis Medications Product Portfolios and Specifications
Table 74. Abbott Prescription Arthritis Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Abbott Main Business
Table 76. Abbott Latest Developments
Table 77. Amgen Basic Information, Prescription Arthritis Medications Manufacturing Base, Sales Area and Its Competitors
Table 78. Amgen Prescription Arthritis Medications Product Portfolios and Specifications
Table 79. Amgen Prescription Arthritis Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. Boehringer Ingelheim Basic Information, Prescription Arthritis Medications Manufacturing Base, Sales Area and Its Competitors
Table 83. Boehringer Ingelheim Prescription Arthritis Medications Product Portfolios and Specifications
Table 84. Boehringer Ingelheim Prescription Arthritis Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Boehringer Ingelheim Main Business
Table 86. Boehringer Ingelheim Latest Developments
Table 87. Horizon Pharma Basic Information, Prescription Arthritis Medications Manufacturing Base, Sales Area and Its Competitors
Table 88. Horizon Pharma Prescription Arthritis Medications Product Portfolios and Specifications
Table 89. Horizon Pharma Prescription Arthritis Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Horizon Pharma Main Business
Table 91. Horizon Pharma Latest Developments
Table 92. Novartis Basic Information, Prescription Arthritis Medications Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis Prescription Arthritis Medications Product Portfolios and Specifications
Table 94. Novartis Prescription Arthritis Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. Pfizer Basic Information, Prescription Arthritis Medications Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Prescription Arthritis Medications Product Portfolios and Specifications
Table 99. Pfizer Prescription Arthritis Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Regeneron Basic Information, Prescription Arthritis Medications Manufacturing Base, Sales Area and Its Competitors
Table 103. Regeneron Prescription Arthritis Medications Product Portfolios and Specifications
Table 104. Regeneron Prescription Arthritis Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Regeneron Main Business
Table 106. Regeneron Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Prescription Arthritis Medications
Figure 2. Prescription Arthritis Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Arthritis Medications Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Prescription Arthritis Medications Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Prescription Arthritis Medications Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Prescription Arthritis Medications Sales Market Share by Country/Region (2024)
Figure 10. Prescription Arthritis Medications Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Topical
Figure 13. Global Prescription Arthritis Medications Sales Market Share by Type in 2025
Figure 14. Global Prescription Arthritis Medications Revenue Market Share by Type (2020-2025)
Figure 15. Prescription Arthritis Medications Consumed in Hospital Pharmacies
Figure 16. Global Prescription Arthritis Medications Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 17. Prescription Arthritis Medications Consumed in Online Pharmacies
Figure 18. Global Prescription Arthritis Medications Market: Online Pharmacies (2020-2025) & (K Units)
Figure 19. Prescription Arthritis Medications Consumed in Retail Pharmacies
Figure 20. Global Prescription Arthritis Medications Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 21. Global Prescription Arthritis Medications Sale Market Share by Application (2024)
Figure 22. Global Prescription Arthritis Medications Revenue Market Share by Application in 2025
Figure 23. Prescription Arthritis Medications Sales by Company in 2025 (K Units)
Figure 24. Global Prescription Arthritis Medications Sales Market Share by Company in 2025
Figure 25. Prescription Arthritis Medications Revenue by Company in 2025 ($ millions)
Figure 26. Global Prescription Arthritis Medications Revenue Market Share by Company in 2025
Figure 27. Global Prescription Arthritis Medications Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Prescription Arthritis Medications Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Prescription Arthritis Medications Sales 2020-2025 (K Units)
Figure 30. Americas Prescription Arthritis Medications Revenue 2020-2025 ($ millions)
Figure 31. APAC Prescription Arthritis Medications Sales 2020-2025 (K Units)
Figure 32. APAC Prescription Arthritis Medications Revenue 2020-2025 ($ millions)
Figure 33. Europe Prescription Arthritis Medications Sales 2020-2025 (K Units)
Figure 34. Europe Prescription Arthritis Medications Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Prescription Arthritis Medications Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Prescription Arthritis Medications Revenue 2020-2025 ($ millions)
Figure 37. Americas Prescription Arthritis Medications Sales Market Share by Country in 2025
Figure 38. Americas Prescription Arthritis Medications Revenue Market Share by Country (2020-2025)
Figure 39. Americas Prescription Arthritis Medications Sales Market Share by Type (2020-2025)
Figure 40. Americas Prescription Arthritis Medications Sales Market Share by Application (2020-2025)
Figure 41. United States Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Prescription Arthritis Medications Sales Market Share by Region in 2025
Figure 46. APAC Prescription Arthritis Medications Revenue Market Share by Region (2020-2025)
Figure 47. APAC Prescription Arthritis Medications Sales Market Share by Type (2020-2025)
Figure 48. APAC Prescription Arthritis Medications Sales Market Share by Application (2020-2025)
Figure 49. China Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 53. India Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Prescription Arthritis Medications Sales Market Share by Country in 2025
Figure 57. Europe Prescription Arthritis Medications Revenue Market Share by Country (2020-2025)
Figure 58. Europe Prescription Arthritis Medications Sales Market Share by Type (2020-2025)
Figure 59. Europe Prescription Arthritis Medications Sales Market Share by Application (2020-2025)
Figure 60. Germany Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 61. France Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Application (2020-2025)
Figure 68. Egypt Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Prescription Arthritis Medications Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Prescription Arthritis Medications in 2025
Figure 74. Manufacturing Process Analysis of Prescription Arthritis Medications
Figure 75. Industry Chain Structure of Prescription Arthritis Medications
Figure 76. Channels of Distribution
Figure 77. Global Prescription Arthritis Medications Sales Market Forecast by Region (2026-2031)
Figure 78. Global Prescription Arthritis Medications Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Prescription Arthritis Medications Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Prescription Arthritis Medications Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Prescription Arthritis Medications Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Prescription Arthritis Medications Revenue Market Share Forecast by Application (2026-2031)